Global Angioplasty Balloons Market Size, Share, Trends, and Growth Forecast 2026-2033

The angioplasty balloons market is witnessing substantial expansion driven by advancements in cardiovascular intervention techniques and increasing prevalence of cardiovascular diseases worldwide. Industry dynamics reflect strong business growth opportunities fueled by innovation in balloon catheter technologies and rising demand for minimally invasive surgical procedures.

Market Size and Overview 

The Global Angioplasty Balloons Market size is estimated to be valued at USD 2.15 billion in 2026 and is expected to reach USD 3.60 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.

 This robust market forecast underscores a sustained increase in market revenue propelled by growing adoption of angioplasty procedures globally. Increasing incidences of coronary artery disease (CAD) are expanding the market scope, while market insights highlight significant growth opportunities in emerging economies.

Market Drivers 

- Rising Cardiovascular Disease Prevalence: The primary market driver is the burgeoning incidence of cardiovascular diseases, particularly coronary artery disease. According to the American Heart Association’s 2024 report, CAD affects over 18 million adults in the U.S. alone, driving demand for angioplasty balloons.

 Innovations such as drug-coated angioplasty balloons (DCBs) are being increasingly adopted to reduce restenosis rates, significantly influencing market growth. Market companies are capitalizing on these trends by introducing technologically advanced, cost-effective balloon catheters, further propelling Angioplasty Balloons Market revenue.

PEST Analysis 

- Political: Government healthcare initiatives promoting minimally invasive surgeries have led to increased reimbursements for angioplasty procedures in regions like North America and Europe (2024 healthcare policy reforms). These policies support market growth and influence investment decisions in the angioplasty balloons market. 

- Economic: Despite global economic uncertainties in 2024, healthcare expenditure has shown resilience, with a 5% increase in funding for cardiovascular disease treatments in emerging markets, boosting industry size and market opportunities. 

- Social: Growing awareness regarding cardiovascular health and lifestyle diseases has increased patient demand for improved treatment options such as angioplasty, pushing market dynamics toward enhanced procedural efficacy. Adoption rates surged by 10% in 2025 within urban populations, reflecting shifting social behaviors. 

- Technological: Advancements in balloon catheter design and materials, including biodegradable and drug-eluting technologies introduced by leading market players in 2024-25, have led to improved clinical outcomes. Technological innovations are a core market growth strategy enhancing product portfolios and capturing higher market share.

Promotion and Marketing Initiatives 

- Market players have leveraged digital marketing campaigns coupled with targeted healthcare provider outreach to educate physicians and patients about new angioplasty balloon technologies. For example, Medtronic plc’s 2025 campaign focused on sharing clinical trial results of their latest DCB, resulting in a 15% increase in global product adoption within six months.

 Such promotional initiatives have positively influenced market growth by amplifying awareness and trust among healthcare professionals and end-users.

Key Players 
The angioplasty balloons market features prominent market companies including: 
- Medtronic plc 
- Abbott Laboratories 
- Philips Healthcare 
- Guerbet Group 
- Cook Medical 
- Sirtex Medical Ltd. 
- NuMED Inc. 
- Accumedical Technologies 
- Terumo Corporation 
- Minvasys, Inc. 

Recent strategies among these market players include: 
- Medtronic plc launched an innovative drug-coated balloon in early 2025, which demonstrated a 20% reduction in restenosis, boosting market share significantly. 
- Abbott Laboratories expanded its manufacturing facilities in 2024 to increase production capacity, facilitating faster delivery and improved market coverage. 
- Terumo Corporation entered a strategic partnership with regional distributors in Asia-Pacific in 2025, yielding a 12% rise in regional revenue and broader market penetration. 
These developments illustrate dynamic business growth and evolving market trends, which are shaping the competitive landscape.

FAQs – Angioplasty Balloons Market 

1. Who are the dominant players in the angioplasty balloons market? 
Leading companies include Medtronic plc, Abbott Laboratories, Philips Healthcare, and Terumo Corporation, known for continuous product innovation and strategic expansions.

2. What will be the size of the angioplasty balloons market in the coming years? 
The angioplasty balloons market size is projected to grow from USD 2.15 billion in 2026 to USD 3.60 billion by 2033, at a CAGR of 15%.

3. Which end-user industry has the largest growth opportunity? 
Healthcare providers specializing in cardiovascular disease treatment, particularly hospitals and cardiac care centers, present the largest growth opportunity due to increased angioplasty procedures globally.

4. How will market development trends evolve over the next five years? 
Market trends indicate a shift toward drug-coated and biodegradable angioplasty balloons, enhanced by technological innovations and growing patient demand for less invasive interventions.

5. What is the nature of the competitive landscape and challenges in the angioplasty balloons market? 
The landscape is highly competitive with frequent product launches and technological upgrades; challenges include regulatory approvals and managing costs in developing markets.

6. What go-to-market strategies are commonly adopted in the angioplasty balloons market? 
Market companies rely on strategic partnerships, regional expansions, and clinical evidence-based promotion to drive adoption and enhance market penetration globally.

➣ Get more insights on: Angioplasty Balloons Market

➣ Get this Report in Japanese Language: 血管形成術バルーン市場

➣ Get this Report in Korean Language:혈관성형풍선시장

➣ Read More Related Articles : Major Uses of Guidewires in Cardiovascular and Neurovascular Interventions

About Author

Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.